Page last updated: 2024-11-06

dimecolin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

dimecolin: RN given refers to diiodide; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71519
CHEMBL ID2106291
SCHEMBL ID2732742
MeSH IDM0056829

Synonyms (31)

Synonym
3425-97-6
dimecolonii iodidum [inn-latin]
piperidinium, 2-carboxy-1,1,6-trimethyl-, iodide, ester with choline iodide
of 1299
dimecolonium iodide
dimekolin
1,1,6-trimethyl-2-((2-(trimethylammonio)ethoxy)carbonyl)piperidinium, diiodide
piperidinium, 1,1,6-trimethyl-2-((2-(trimethylammonio)ethoxy)carbonyl)-, diiodide
dimecoline iodide
ester of 2-carboxy-1,1,6-trimethylpiperidinium iodide with (2-hydroxyethyl) trimethylammonium iodide
dimecholine
dimecolonium iodide [inn]
dimecoline
iodure de dimecolonium [inn-french]
dimecolin
ioduro de dimecolonio [inn-spanish]
1,1,6-trimethyl-2-((2-(trimethylammonio)ethoxy)carbonyl)piperidinium diiodid
dimecolonii iodidum
iodure de dimecolonium
1,1,6-trimethyl-2-((2-(trimethylammonio)ethoxy)carbonyl)piperidinium diiodid [iupac]
ioduro de dimecolonio
4d4nc8mxlw ,
unii-4d4nc8mxlw
1,1,6-trimethyl-2-(beta-trimethylammoniumethoxycarbonyl)piperidinium diiodide
CHEMBL2106291
piperidinium, 1,1,2-trimethyl-6-((2-(trimethylammonio)ethoxy)carbonyl)-, iodide (1:2)
SCHEMBL2732742
Q4161654
trimethyl-[2-(1,1,6-trimethylpiperidin-1-ium-2-carbonyl)oxyethyl]azanium;diiodide
1,1,2-trimethyl-6-{[2-(trimethylazaniumyl)ethoxy]carbonyl}piperidin-1-ium diiodide
DTXSID50955793
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (57.14)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]